Subscribe Login
DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
A-Brands

Mild Weather, Private Label Impact Reckitt Benckiser's OTC Division In Q1

Milder weather, retailer destocking and increased private label competition have all been cited by hygiene and health products maker Reckitt Benckiser as factors contributing to a 9% dip in its Over-The-Counter (OTC) division in the first quarter.

The division includes brands such as Nurofen and Gaviscon, as well as chest congestion brand Mucinex, the latter of which experienced share loss due to 'private label competition' in its category, the group said.

Sales in the OTC division stood at £470 million for the quarter.

PLEASE SUBSCRIBE OR SIGN IN TO CONTINUE READING

30 Day Free Trial

Try European Supermarket Magazine Premium

Enjoy full access to European Supermarket Magazine, our weekly
email news digest, access to all website and app content, and the latest digital
magazine for a full 30 days.

  • - Payment details required during trial sign up.
  • - You may cancel at any time up to the end of the 30-day trial period.
  • - If you continue after the trial perion, then the annual rate of €109+VAT will be debited.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our Terms & Conditions and Privacy Policy
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days